Interventions for chronic kidney disease-associated restless legs syndrome

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 9, 2013, Pages

  Gopaluni, Seerapani ^a   Sherif, Mohamed ^a   Ahmadouk, Naim A ^b  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b BUCKINGHAMSHIRE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; DOPAMINE RECEPTOR STIMULATING AGENT; IRON; MINERAL; NUTRITION SUPPLEMENT; VITAMIN;

ALCOHOL ABSTINENCE; ANEMIA; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; DISEASE ASSOCIATION; EXERCISE; HUMAN; KIDNEY TRANSPLANTATION; OUTCOME ASSESSMENT; PATIENT SAFETY; PHARMACEUTICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; RESTLESS LEGS SYNDROME; RISK BENEFIT ANALYSIS; SMOKING CESSATION; SYSTEMATIC REVIEW;

EID: 84994503434     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD010690     Document Type: Article

References (18)

1. Agarwal P, Sia C, Vaish N, Roy-Faderman I. Pilot trial of onabotulinumtoxina (Botox) in moderate to severe restless legs syndrome. International Journal of Neuroscience 2011;121(11):622-5. [MEDLINE: 21740308]
2. Akpinar S. Treatment of restless legs syndrome with levodopa plus benserazide. Archives of Neurology 1982;39(11):739. [MEDLINE: 7126008]
3. Al-Jahdali HH, Al-Qadhi WA, Khogeer HA, Al-Hejaili FF, Al-Ghamdi SM, Al Sayyari AA. Restless legs syndrome in patients on dialysis. Saudi Journal of Kidney Diseases & Transplantation 2009;20(3):378-85. [MEDLINE: 19414938]
4. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Medicine 2003;4(2):101-19. [MEDLINE: 14592341]
5. Ekbom K. Restless legs. Acta Medica Scandinavica 1945;121(S158):7-123.
6. Giannaki CD, Sakkas GK, Hadjigeorgiou GM, Karatzaferi C, Patramani G, Lavdas E, et al. Non-pharmacological management of periodic limb movements during hemodialysis session in patients with uremic restless legs syndrome. ASAIO Journal 2010;56(6):538-42. [MEDLINE: 21245801]
7. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60. [MEDLINE: 12958120]
8. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
9. Hornyak M, Scholz H, Kohnen R, Bengel J, Kassubek J, Trenkwalder C. What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medications. Sleep Medicine Reviews 2013;pii: S1087-0792(13):00031-2. [PUBMED: 23746768]
10. Kavanagh D, Siddiqui S, Geddes CC. Restless legs syndrome in patients on dialysis. American Journal of Kidney Diseases 2004;43(5):763-71. [MEDLINE: 15112166]
11. La Manna G, Pizza F, Persici E, Baraldi O, Comai G, Cappuccilli ML, et al. Restless legs syndrome enhances cardiovascular risk and mortality in patients with end-stage kidney disease undergoing long-term haemodialysis treatment. Nephrology Dialysis Transplantation 2011;26(6):1976-83. [MEDLINE: 21056943]
12. Manley HJ, McClaran ML, Overbay DK, Wright MA, Reid GM, Bender WL, et al. Factors associated with medication-related problems in ambulatory hemodialysis patients. American Journal of Kidney Diseases 2003;41(2):386-93. [MEDLINE: 12552501]
13. Mucsi I, Molnar MZ, Ambrus C, Szeifert L, Kovacs AZ, Zoller R, et al. Restless legs syndrome, insomnia and quality of life in patients on maintenance dialysis. Nephrology Dialysis Transplantation 2005;20(3):571-7. [MEDLINE: 15671074]
14. Sloand JA, Shelly MA, Feigin A, Bernstein P, Monk RD. A double blind placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome. American Journal of Kidney Diseases 2004;43(4):663-70. [MEDLINE: 15042543]
15. Sun ER, Chen CA, Ho G, Earley CJ, Allen RP. Iron and the restless legs syndrome. Sleep 1998;21(4):371-7. [MEDLINE: 9646381]
16. Walters AS. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Movement Disorders 1995;10(5):634-42. [MEDLINE: 8552117]
17. Walters A, Rye D. Evidence continues to mount on the relationship of restless legs syndrome/periodic limb movements in sleep to hypertension, cardiovascular disease, and stroke. Sleep 2010;33(3):287. [MEDLINE: 20337185]
18. Winkelmann J, Schadrack J, Wetter TC, Zieglgansberger W, Trenkwalder C. Opioid and dopamine antagonist drug challenges in untreated restless legs syndrome patients. Sleep Medicine 2001;2(1):57-61. [EMBASE: 2001086037]